CBSE Board Exam 2022: Term-wise revised syllabus released at cbseacademic.nic.in; find direct link here

-

The revised syllabus for the Class 10 and Class 12 board examinations for the academic year 2021- 2022 has been released by the Central Board of Secondary Education (CBSE).

In continuation of its new assessment policy announced recently, the board has also issued its revised term-wise syllabus for Classes 9 to 12.

The detailed information related to the revised syllabus for all the subjects has been released on the official website of CBSE - cbseacademic.nic.in.

As per the latest update, the complete syllabus has been reduced. From the total curriculum that is set, 50 percent would be completed in Term I and the remaining 50 percent will be done in Term II. Following which students would be required to appear for the Term End Examinations.

In the new scheme, Term I will have multiple-choice questions (MCQ) while Term II will be subjective as well as MCQ-based. Also, sample papers for the revised curriculum would be released in due course of time by the board.

The board has also issued guidelines for schools to conduct Internal Assessments or Practical projects.

Check direct link to Term Wise Syllabus here: cbseacademic.nic.in/Term-wise-curriculum_2022.html

Meanwhile, CBSE has directed all respective schools under the board to share the term-wise syllabus and guidelines with all teachers and students. So that the conduct of board examinations and Internal assessments or projects can be taken up as per the new policy.

Students and teachers are both advised to check the detailed syllabus online. However, parents are requested to connect with their respective teachers regarding the same.

Earlier this month, the board had announced the new assessment scheme for next year's Class 10 and 12 examinations as a measure to avoid cancelling the boards amid coronavirus crisis, like this year.



from Firstpost India Latest News https://ift.tt/3y3vdHu
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more